Cargando…
Inhaled budesonide for early treatment of COVID-19
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115939/ https://www.ncbi.nlm.nih.gov/pubmed/33991508 http://dx.doi.org/10.1016/S2213-2600(21)00211-3 |
| _version_ | 1783691291107786752 |
|---|---|
| author | San-Juan, Rafael Fernández-Ruiz, Mario López-Medrano, Francisco Aguado, José María |
| author_facet | San-Juan, Rafael Fernández-Ruiz, Mario López-Medrano, Francisco Aguado, José María |
| author_sort | San-Juan, Rafael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8115939 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81159392021-05-13 Inhaled budesonide for early treatment of COVID-19 San-Juan, Rafael Fernández-Ruiz, Mario López-Medrano, Francisco Aguado, José María Lancet Respir Med Correspondence Elsevier Ltd. 2021-07 2021-05-12 /pmc/articles/PMC8115939/ /pubmed/33991508 http://dx.doi.org/10.1016/S2213-2600(21)00211-3 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence San-Juan, Rafael Fernández-Ruiz, Mario López-Medrano, Francisco Aguado, José María Inhaled budesonide for early treatment of COVID-19 |
| title | Inhaled budesonide for early treatment of COVID-19 |
| title_full | Inhaled budesonide for early treatment of COVID-19 |
| title_fullStr | Inhaled budesonide for early treatment of COVID-19 |
| title_full_unstemmed | Inhaled budesonide for early treatment of COVID-19 |
| title_short | Inhaled budesonide for early treatment of COVID-19 |
| title_sort | inhaled budesonide for early treatment of covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115939/ https://www.ncbi.nlm.nih.gov/pubmed/33991508 http://dx.doi.org/10.1016/S2213-2600(21)00211-3 |
| work_keys_str_mv | AT sanjuanrafael inhaledbudesonideforearlytreatmentofcovid19 AT fernandezruizmario inhaledbudesonideforearlytreatmentofcovid19 AT lopezmedranofrancisco inhaledbudesonideforearlytreatmentofcovid19 AT aguadojosemaria inhaledbudesonideforearlytreatmentofcovid19 |